Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Takes “Authorized” Generics Fight To Congress, FTC, Courts

Executive Summary

Mylan is taking its fight against "authorized" generics beyond FDA to Capitol Hill, the Federal Trade Commission and the federal courts

You may also be interested in...



FTC Should Study Competitive Impact Of “Authorized” Generics, Senators Say

A bipartisan group of senators is asking the Federal Trade Commission to study the competitive impact of "authorized" generics

FTC Should Study Competitive Impact Of “Authorized” Generics, Senators Say

A bipartisan group of senators is asking the Federal Trade Commission to study the competitive impact of "authorized" generics

Teva Anticipates “Major Consolidation” In Generic Industry In 2005

Teva is preparing for another round of consolidation within the generic industry during 2005, North America CEO George Barrett said Jan. 13 at the J.P. Morgan health care conference in San Francisco

Related Content

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel